Full text is available at the source.
Abstract
Distinct microbial patterns may serve as non-invasive diagnostic and prognostic biomarkers for breast cancer.
- The gut microbiome is linked to breast cancer diagnosis, progression, and treatment.
- Microbial composition could aid in patient stratification and risk assessment.
- Alterations in gut bacteria may influence estrogen metabolism and the risk of hormone receptor-positive breast cancer.
- Dysbiosis is associated with chronic inflammation and tumor growth.
- Gut bacteria may affect responses to chemotherapy and immunotherapy, potentially enhancing treatment efficacy.
- Early studies are investigating the use of probiotics, prebiotics, and fecal microbiota transplantation to restore microbial balance and improve treatment outcomes.
Simplified